Current Status of Potential Therapies for IgE-Mediated Food Allergy

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2018 Feb 23

PMID 29470658

Citations 1

Authors

Christopher P Parrish

Daniel Har

J Andrew Bird

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The goal of this review is to provide the reader with an updated summary of published trial data regarding the use of oral immunotherapy (OIT), sublingual immunotherapy (SLIT), and epicutaneous immunotherapy (EPIT) for treatment of IgE-mediated food allergies.

Recent Findings: Data from phase 2 trials for treatment of peanut allergy with OIT and EPIT reveal an increase in the threshold of reactivity for peanut-allergic children. Compared to EPIT, OIT promotes a greater increase in the threshold of reactivity; however, adverse events are more common with OIT. OIT, EPIT, and SLIT appear to modulate the immune response for some food-allergic individuals. Data regarding utility for treatment of food allergies regardless of modality is limited to few foods, as is investigation into treatment of food-allergic infants, young children, and adults. Future trials are likely to focus on young children, food allergies other than peanut, and treatment of multifood-allergic individuals.

Citing Articles

Amelioration Effect of ZW3 on Ovalbumin-Induced Allergic Symptoms in BALB/c Mice.

Xu H, Duan X, Wang Y, Geng W Foods. 2025; 14(1.

PMID: 39796306 PMC: 11720023. DOI: 10.3390/foods14010016.

Mechanisms of oral immunotherapy.

Barshow S, Kulis M, Burks A, Kim E Clin Exp Allergy. 2021; 51(4):527-535.

PMID: 33417257 PMC: 9362513. DOI: 10.1111/cea.13824.

References

Begin P, Dominguez T, Wilson S, Bacal L, Mehrotra A, Kausch B . Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol. 2014; 10(1):7. PMC: 3936817. DOI: 10.1186/1710-1492-10-7. View

Lucendo A, Arias A, Tenias J . Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014; 113(6):624-9. DOI: 10.1016/j.anai.2014.08.004. View

Drachenberg K, Wheeler A, Stuebner P, Horak F . A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy. 2001; 56(6):498-505. DOI: 10.1034/j.1398-9995.2001.056006498.x. View

Narisety S, Skripak J, Steele P, Hamilton R, Matsui E, Burks A . Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2009; 124(3):610-2. PMC: 2739248. DOI: 10.1016/j.jaci.2009.06.025. View

Tang M, Ponsonby A, Orsini F, Tey D, Robinson M, Su E . Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J Allergy Clin Immunol. 2015; 135(3):737-44.e8. DOI: 10.1016/j.jaci.2014.11.034. View

Bird J, Spergel J, Jones S, Rachid R, Assaad A, Wang J . Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2017; 6(2):476-485.e3. DOI: 10.1016/j.jaip.2017.09.016. View

Mansfield L . Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol. 2006; 97(2):266-7. DOI: 10.1016/S1081-1206(10)60026-9. View

Srivastava K, Siefert A, Fahmy T, Caplan M, Li X, Sampson H . Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy. J Allergy Clin Immunol. 2016; 138(2):536-543.e4. DOI: 10.1016/j.jaci.2016.01.047. View

Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A . Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy. 2008; 38(11):1819-29. DOI: 10.1111/j.1365-2222.2008.03056.x. View

10.

Dunn Galvin A, McMahon S, Ponsonby A, Hsiao K, Tang M . The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life. Allergy. 2017; 73(3):560-568. DOI: 10.1111/all.13330. View

11.

Sampson H, Leung D, Burks A, Lack G, Bahna S, Jones S . A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol. 2011; 127(5):1309-10.e1. DOI: 10.1016/j.jaci.2011.01.051. View

12.

Keet C, Frischmeyer-Guerrerio P, Thyagarajan A, Schroeder J, Hamilton R, Boden S . The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2011; 129(2):448-55, 455.e1-5. PMC: 3437605. DOI: 10.1016/j.jaci.2011.10.023. View

13.

Gupta N, Aron A . Urges for food and money spill over into motor system excitability before action is taken. Eur J Neurosci. 2010; 33(1):183-8. PMC: 4420634. DOI: 10.1111/j.1460-9568.2010.07510.x. View

14.

Sicherer S, Wood R, Vickery B, Jones S, Liu A, Fleischer D . The natural history of egg allergy in an observational cohort. J Allergy Clin Immunol. 2014; 133(2):492-9. PMC: 3959659. DOI: 10.1016/j.jaci.2013.12.1041. View

15.

Rodriguez Del Rio P, Diaz-Perales A, Sanchez-Garcia S, Escudero C, do Santos P, Catarino M . Oral immunotherapy in children with IgE-mediated wheat allergy: outcome and molecular changes. J Investig Allergol Clin Immunol. 2014; 24(4):240-8. View

16.

De Boissieu D, Dupont C . Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy. 2006; 61(10):1238-9. DOI: 10.1111/j.1398-9995.2006.01196.x. View

17.

Begin P, Winterroth L, Dominguez T, Wilson S, Bacal L, Mehrotra A . Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol. 2014; 10(1):1. PMC: 3913318. DOI: 10.1186/1710-1492-10-1. View

18.

Narisety S, Frischmeyer-Guerrerio P, Keet C, Gorelik M, Schroeder J, Hamilton R . A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol. 2014; 135(5):1275-82.e1-6. PMC: 4430665. DOI: 10.1016/j.jaci.2014.11.005. View

19.

Hofmann A, Scurlock A, Jones S, Palmer K, Lokhnygina Y, Steele P . Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol. 2009; 124(2):286-91, 291.e1-6. PMC: 2731305. DOI: 10.1016/j.jaci.2009.03.045. View

20.

Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro P . A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy. 2004; 59(9):980-7. DOI: 10.1111/j.1398-9995.2004.00542.x. View